MIRA INFORM REPORT

 

 

Report Date :

01.08.2012

 

IDENTIFICATION DETAILS

 

Name :

CODUPHA - LAO PHARMA CO., LTD

 

 

Registered Office :

120/group 8 Dongpalane Rd.Sisattanak Dist , Vientiane, Laos

 

 

Country :

Viet Nam

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

2000

 

 

Legal Form :

Limited liability company

 

 

Line of Business :

Manufacture of pharmaceuticals, medicinal chemical and botanical products

 

 

No. of Employees :

115

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Viet Nam

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D


SUBJECT IDENTIFICATION & LEGAL FORM

 

Current legal status

English Name

 

CODUPHA - LAO PHARMA CO., LTD

Vietnamese Name

 

CONG TY DUOC PHAM CODUPHA LAO

Trade name

 

CODUPHA LAO

Short name

 

CODUPHA LAO

Type of Business

 

Limited liability company

Established

 

2000

Investment Certificate No

 

2166/GPDC2

Date Of Issuance

 

06 May 2004

Place of Issuance

 

Ministry of Planning and Investment of Vietnam

Registered Investment Capital

 

USD 900,000

Chartered capital

 

USD 900,000

Duration

 

15 years

Total Employees

 

115

 

Historical Identification & Legal form

 

List

Changed Items

1

Subject has got former Registered English Name: KPN LAOS - VIET PHARMA CO., LTD Changed to: CODUPHA - LAO PHARMA CO., LTD

2

Subject has got former Registered Vietnamese Name: CONG TY TNHH KPN LAOS - VIET

Changed to: CONG TY DUOC PHAM CODUPHA -LAO

 

 

 

ADDRESSES

 

Head Office

Address

 

120/group 8 Dongpalane Rd.Sisattanak Dist , Vientiane, Laos

Telephone

 

00856.21.263137

Fax

 

00856.21.223450

 

 

DIRECTORS

 

1. NAME

 

Mr. NGUYEN DUC THANG

Position

 

Director

Nationality

 

Vietnamese

 

2. NAME

 

Ms. DAOPHET THIPPHAVONG

Position

 

Chief Accountant

Nationality

 

Laos

 

 

 

BUSINESS NATURE AND ACTIVITIES

 

Manufacture of pharmaceuticals, medicinal chemical and botanical products

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT:

·         Types of products

 

materials

·         Market

 

Vietnam, EU

 

EXPORT:

·         Market

 

Vietnam, Asia, Singapore

 

 

 

BANKERS

 

CITI BANK - BRANCH IN HO CHI MINH CITY

Address

 

No. 115 Nguyen Hue Str, Ben Nghe Ward,  District 1, Ho Chi Minh City, Vietnam

Telephone

 

(84-8) 38242118

Fax

 

(84-8) 38242267

 

 

SHAREHOLDERS

 

1. NAME

 

CENTRAL PHARMACEUTICAL COMPANY NO.2

Business Registration

 

0300483319

Date of Registration

 

18 Aug 2010

Place of Registration

 

Business Registration Office – Planning and Investment Department of Hochiminh City

Registered Capital

 

VND  102,777,872,638

Tax code

 

0300483319

Address

 

No. 334 (former No.136)To Hien Thanh Str, Ward 14 , District 10, Ho Chi Minh City, Vietnam

Tel

 

(84-8) 38650938 – 38658638

Fax

 

(84-8) 38650750 – 38665840

Email

 

codupha@hcm.fpt.vn

Website

 

www.codupha.com.vn

Value of shares

 

USD 843,300

Percentage

 

93.7%

 

2. NAME

 

KAMPHENG NAKHORN PHATTHANA CO., LTD

Address

 

Laos

Value of shares

 

USD 56,700

Percentage

 

6.3%

 

 

 

FINANCIAL DATA

 

BALANCE SHEET

Unit: One LAK

Balance sheet date

31/12/2011

31/12/2010

Number of weeks

52

52

ASSETS

A – CURRENT ASSETS

19,428,450,179.14

15,943,642,758.97

I. Cash and cash equivalents

944,489,586.89

373,999,793.13

1. Cash

944,489,586.89

373,999,793.13

2. Cash equivalents

.00

.00

II. Short-term investments

.00

.00

1. Short-term investments

.00

.00

2. Provisions for devaluation of short-term investments

.00

.00

III. Accounts receivable

2,893,010,104.38

4,398,472,259.80

1. Receivable from customers

1,445,549,333.01

2,875,947,281.06

2. Prepayments to suppliers

.00

.00

3. Inter-company receivable

.00

.00

4. Receivable according to the progress of construction

.00

.00

5. Other receivable

1,447,460,771.37

1,522,524,978.74

6. Provisions for bad debts

.00

.00

IV. Inventories

15,590,950,487.87

11,171,170,706.04

1. Inventories

15,590,950,487.87

11,171,170,706.04

2. Provisions for devaluation of inventories

.00

.00

V. Other Current Assets

.00

.00

1. Short-term prepaid expenses

.00

.00

2. VAT to be deducted

.00

.00

3. Taxes and other accounts receivable from the State

.00

.00

4. Other current assets

.00

.00

B. LONG-TERM ASSETS

6,485,814,038.72

7,395,673,436.72

I. Long term accounts receivable

.00

.00

1. Long term account receivable from customers

.00

.00

2. Working capital in affiliates

.00

.00

3. Long-term inter-company receivable

.00

.00

4. Other long-term receivable

.00

.00

5. Provisions for bad debts from customers

.00

.00

II. Fixed assets

6,485,814,038.72

7,395,673,436.72

1. Tangible assets

6,337,314,038.72

7,023,373,358.72

- Historical costs

6,337,314,038.72

7,023,373,358.72

- Accumulated depreciation

.00

.00

2. Financial leasehold assets

.00

.00

- Historical costs

.00

.00

- Accumulated depreciation

.00

.00

3. Intangible assets

148,500,000.00

148,500,000.00

- Initial costs

148,500,000.00

148,500,000.00

- Accumulated amortization

.00

.00

4. Construction-in-progress

.00

223,800,078.00

III. Investment property

.00

.00

Historical costs

.00

.00

Accumulated depreciation

.00

.00

IV. Long-term investments

.00

.00

1. Investments in affiliates

.00

.00

2. Investments in business concerns and joint ventures

.00

.00

3. Other long-term investments

.00

.00

4. Provisions for devaluation of long-term investments

.00

.00

V. Other long-term assets

.00

.00

1. Long-term prepaid expenses

.00

.00

2. Deferred income tax assets

.00

.00

3. Other long-term assets

.00

.00

TOTAL ASSETS

25,914,264,217.86

23,339,316,195.69

LIABILITES

 

A- LIABILITIES

17,033,534,251.25

14,487,778,728.72

I. Current liabilities

17,033,534,251.25

14,487,778,728.72

1. Short-term debts and loans

.00

 

2. Payable to suppliers

11,172,430,261.5100

7,624,487,020.29

3. Advances from customers

.00

.00

4. Taxes and other obligations to the State Budget

.00

.00

5. Payable to employees

.00

.00

6. Accrued expenses

.00

.00

7. Inter-company payable

.00

.00

8. Payable according to the progress of construction contracts

.00

.00

9. Other payable

60,519,794.74

130,773,728.27

10. Provisions for short-term accounts payable

5,800,584,195.00

6,732,517,980.16

II. Long-Term Liabilities

.00

.00

1. Long-term accounts payable to suppliers

.00

.00

2. Long-term inter-company payable

.00

.00

3. Other long-term payable

.00

.00

4. Long-term debts and loans

.00

.00

5. Deferred income tax payable

.00

.00

6. Provisions for unemployment allowances

.00

.00

7. Provisions for long-term accounts payable

.00

.00

B- OWNER’S EQUITY

8,880,729,966.61

8,851,537,466.97

I. OWNER’S EQUITY

8,880,729,966.61

8,851,537,466.97

1. Capital

8,714,684,125.00

8,714,684,125.00

2. Share premiums

.00

.00

3. Other sources of capital

.00

60,547,674.97

4. Treasury stocks

.00

.00

5. Differences on asset revaluation

.00

.00

6. Foreign exchange differences

.00

.00

7. Business promotion fund

.00

.00

8. Financial reserved fund

.00

.00

9. Other funds

76,305,667.00

76,305,667.00

10. Retained earnings

89,740,174.61

.00

11. Construction investment fund

.00

.00

II. Other sources and funds

.00

.00

1. Bonus and welfare funds

.00

.00

2. Sources of expenditure

.00

.00

3. Fund to form fixed assets

.00

.00

MINORITY’S INTEREST

.00

.00

TOTAL LIABILITIES & OWNER’S EQUITY

25,914,264,217.86

23,339,316,195.69

 

 

PROFIT & LOSS STATEMENT

 

Description

FY2011

1. Total Sales

10,252,205,762.54

2. Deduction item

0

3. Net revenue

10,252,205,762.54

4. Costs of goods sold

7,664,804,690.51

5. Gross profit

2,587,401,072.03

6. Financial income

648,948,138.34

7. Financial expenses

594,127,412.77

- In which: Loan interest expenses

 

8. Selling expenses

 

9. Administrative overheads

828,479,661.00

10. Net operating profit

1,813,742,136.60

11. Other income

980,700,032.00

12. Other expenses

266,151,166.26

13. Other profit /(loss)

714,548,865.74

14. Total accounting profit before tax

2,528,291,002.34

15. Current corporate income tax

0

16. Deferred corporate income tax

0

18. Profit after tax

2,528,291,002.34

 

 

FINANCIAL RATIOS AND AVERAGE INDUSTRY RATIOS

 

Description

FY2011

Average Industry

Current liquidity ratio

1.14

1.65

Quick liquidity ratio

0.23

1.04

Inventory circle

1.39

4.14

Average receive period

44.67

105.37

Utilizing asset performance

0.91

1.20

Liability by total assets

65.73

53.11

Liability by owner's equity

191.80

159.74

Ebit / Total assets (ROA)

4.78

10.37

Ebit / Owner's equity (ROE)

13.96

23.03

Ebit / Total revenue (NPM)

5.24

10.15

Gross profit / Total revenue (GPM)

21.29

25.88

Note: The Average Industry was calculated by VietnamCredit based on our own statistical data

 

 

 

PAYMENT HISTORY & PERFORMANCE EXPERIENCES

 

Trade Morality

 

Fair

Liquidity

 

Low/Medium

Payment status

 

Above Average

Financial Situation

 

Average

Development trend

 

Stable

Litigation data

 

No Record

Bankruptcy

 

No Record

Payment Methods

 

Direct of through the bank

Sale Methods

 

Wholesaler

 

 

 

INTERPRETATION ON THE SCORES

 

The subject is joint venture between CENTRAL PHARMACEUTICAL COMPANY NO.2

(CODUPHA) and KAMPHENG NAKHORN PHATTHANA. The subject was established in 2000 under Investment Certificate No. 2166/GP with total investment and chartered capital US$ 900,000. In which, CODUPHA is biggest investor with 93.7 % capital.

Currently, most of activities of the subject are run by Mr. NGUYEN DUC THANG. Board of Director are 5 Vietnameses. The subject has about 125 employees now. Financial capacity is fair thanks to supports from CODUPHA. In Vietnam, CODUPHA is big company which specializes in manufacturing, trading trading, distributing, and marketing pharmaceutical formulations, pharmaceutical raw materials, cosmetics and nutritional products. CODUPHA LAO operates as factory of CODUPHA. According to our source, the subject  adjusted  Investment Certificate on 06 May 2004.

We visited CODUPHA in Vietnam and have an interview with Accounting Department of CODUPHA. According to Ms. Thao-accountant, business situation of  CODUPHA LAO was developing and stable now.

The subject has a lot of opportunities such as: cheap labour, financial capacity, supports of Government…In general, the subject has capacity to meet normal financial commitments

 

 

 

 

 


APPENDIX

 

INDUSTRY DATA

Industry code

Growth speed by price compared with 1994 (%)

Total enterprises 2009

Total employees 2010

(Thous.pers.)

Annual average capital of enterprises 2009

(billion dongs)

2011

2010

Agriculture, Forestry and Fishing

4.00

2.78

8,749

23,896.3

81,559

Industry and Construction

5.53

7.70

85,115

10,630

2,751,975

Trade and Services

6.69

7.52

154,978

14,522

4,939,069

 

ECONOMIC INDICATORS

 

2011 

2010 

2009 

Population (Million person)

87.84

86.93

86.02

Gross Domestic Products (USD billion)

119

102.2

91

GDP Growth (%)

5.89

6.78

5.32

GDP Per Capita (USD/person/year)

1,300

1,160

1,080

Inflation (% Change in Composite CPI)

18.58

11.75

6.88

State Budget Deficit compared with GDP (%)

4.9

5.8

6.9

 

SERVICE TRADE PERFORMANCE

 

Billion USD 

2011 

2010 

2009 

Exports

96.3

72.2

57.1

Imports

105.8

84.8

69.9

Trade Balance

-9.5

-12.6

-12.8

Source: General Statistics Office


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.80

UK Pound

1

Rs.87.66

Euro

1

Rs.68.45

 

 

INFORMATION DETAILS

 

Report Prepared by :

PDT

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.